Philadelphia Overdose Deaths Fall 18% to 1,069 as Black Fatalities Drop 27% and Stimulant Cases Rise
Updated
Updated · The Philadelphia Inquirer · May 25
Philadelphia Overdose Deaths Fall 18% to 1,069 as Black Fatalities Drop 27% and Stimulant Cases Rise
1 articles · Updated · The Philadelphia Inquirer · May 25
Summary
1,069 Philadelphians died of overdoses in 2024, down 18% from 2023 and marking the city’s second straight annual decline after a 2022 peak of 1,413.
Black residents saw the sharpest improvement, with fatal overdoses down 27%; Hispanic deaths fell 26% and white deaths 4%, a shift officials linked to broader outreach, naloxone access and community education.
Stimulant-only overdose deaths still rose 8.6%, and seven in 10 of those deaths involved Black residents—especially men over 45—highlighting weaker treatment options beyond opioids.
Fentanyl remained present in most fatal cases, while xylazine was involved in 364 deaths and medetomidine in 92, underscoring risks from an increasingly contaminated drug supply.
Preliminary state data show Philadelphia’s overdose deaths may have fallen further to 921 in 2025, which would put the city below 1,000 for the first time in nearly a decade if confirmed.